Ophthalmic Genetics

Ophthalmic genetics includes determination of patterns and risks of inheritance and development of treatments for genetic diseases. Vitamin A deficiency is the leading cause of preventable blindness in children worldwide and results in a well-recognized ocular phenotype. It is also includes the several technique in correcting the defective gene by using application of biotechnology techniques such as gene therapy. Ophthalmic genetics or ophthalmic gene therapy can process through by following methods like ocular gene transfer methods. They have been several diseases which have been cured by gene therapy like retinitis pigmentosa and ARMD.

 

 

  • Abnormalities of Nuclear or Mitochondrial DNA
  • Autosomal dominant disorders
  • Autosomal recessive disorders
  • X-linked recessive disorders
  • Matrilineal inheritance
  • Chromosomal Abnormalities

Related Conference of Ophthalmic Genetics

October 20-21, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
November 03-04, 2025

39th European Ophthalmology Congress

Rome, Italy
January 12-13, 2026

26th Global Ophthalmologists Annual Meeting

London, UK
April 20-21, 2026

3rd International Conference on Ophthalmology

Barcelona, Spain
May 07-08, 2026

7th International Conference on Optometry

Paris, France
May 25-26, 2026

10th World Congress on Eye and Vision

Madrid, Spain

Ophthalmic Genetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in